Refine Your Search

Acetaminophen use and overuse with focus on signs and symptoms of liver injury, including FDA-recommended potencies for various age cohorts and at-risk populations. When you finish this course, you will be able to: * Identify acetaminophen and its use in combination drugs. * Discuss the causes of unintentional acetaminophen overuse and overdose. * State the signs and symptoms of liver injury from acetaminophen overdose. * Distinguish safe potencies of acetaminophen preparations for infa...

The pharmacologic properties of opioids including their mechanisms of action, receptor targets, target tissues, agonists and antagonists. Clinical applications including accepted usage, duration of action, and the minimizing of side effects. Finally, a look at overdose deaths from opioid abuse. When you finish this course, you will be able to: *Identify the various receptor targets of opioid action and explain how they differ. *List the target tissues of opioids along with their natural...

This course is taught by UF’s faculty with expertise in emergency medicine (MDs), clinical toxicology and pharmacy. Students will learn about: • The history, principles and methods of clinical toxicology • Managing poisoned or overdosed patients • Applying laboratory testing principles • Identifying and applying the basic concepts of toxicokinetics • Differing toxic effects depending on the route of administration • Liberation and absorption of toxicants into the body ...

Statement of Need Identifying and Reporting Doctor Shopping in the United States . Doctor Shopping laws and Prescription Drug Monitoring Programs have been provided in many states in an attempt to control abuse and diversion. Intended Audience Practitioners who prescribe controlled substance medication for pain management Learning Objectives Upon completion of this activity, the participant should be able to: - Explain The Doctor Shopping law in the above listed state or stat...

Objectives 1. Describe the epidemiology and risk factors for drug-induced lung disease. 2. Review the common patterns of drug-induced lung injury. 3. Review the diagnostic evaluation of patients with suspected drug-induced lung disease. 4. Understand the principles of management of drug-induced lung disease. 5. Describe features of drug-induced lung disease due to novel biological agents.

Learning Objectives Upon completion of this activity, participants should be able to: 1. Define drug allergy in relation to adverse drug reactions. 2. Discuss the incidence and risk factors of drug allergies in the general population. 3. Evaluate cross-reactivity between agents to provide alternative recommendations to patients. 4. Describe common drug allergies and the appropriate treatment options. 5. Explain the role of the pharmacist in the management of drug allergies.

Learning Objectives: Upon successful completion of this program, pharmacists should be able to: 1. Identify factors that contribute to the high prevalence of warfarin drug interactions. 2. Describe the typical time course for warfarin drug interactions. 3. Describe mechanisms for warfarin drug interactions. 4. Discuss various types of drugs or drug classes that are known to interact with warfarin. 5. Discuss strategies to manage warfarin drug interactions and minimize risks.

Statement of Need The abuse and diversion of prescription pain medication has increased dramatically throughout the United States. Altering and Counterfeiting prescription sheets have become more popular as a means of making these drugs available on the street. Intended Audience Physicians, Nurse Practitioners, Physician’s Assistants, Medical Assistants Learning Objectives Upon completion of this activity, the participant should be able to: - Identify the elements of the pres...

Statement of Need The abuse and diversion of prescription pain medication has increased dramatically throughout the United States. Altering and Counterfeiting prescription sheets have become more popular as a means of making these drugs available on the street. Intended Audience Physicians, Nurse Practitioners, Physician Assistants, Medical Assistants Learning Objectives Upon completion of this activity, the participant should be able to: - Identify perceived barriers between p...

Learning Objectives 1. Describe the mechanism of action of tapentadol immediate release (IR). 2. Determine the appropriate dose and dosing schedule for tapentadol IR. 3. Recognize tapentadol IR's contraindications, warnings and precautions. 4. Identify adverse effects that have been associated with tapentadol IR. 5. Discuss potential drug-drug interactions with tapentadol IR.

This course provides an understanding of the interrelated activities throughout the drug development cycle, and is designed for anyone interested in learning how drugs are developed, manufactured and subsequently brought to market. This course serves as an introduction to the drug development process and will familiarize participants with the steps involved in developing a drug from discovery to commercialization. Included is an overview of the regulatory and pre-marketing steps that occur to ...

At the completion of this activity, the participant will be able to: Describe the role of the cytochrome P450 system in metabolic drug interactions. Describe general approaches for the avoidance of patient harm resulting from drug interactions. Describe how to evaluate a drug interaction alert from a computerized screening system.

This two-day course is designed for those who manage, audit, or oversee manufacturing of OTC drug products, and for cosmetic manufacturers with OTC drug products (no dosage) performing their operation under a drug cGMP environment. The course will cover regulatory expectations as contained in U.S. and International guidelines. It will prepare attendees to assess their current compliance status, develop strategies and plans for remediation of identified gaps, and execute a plan to achieve comp...

1. Present an overview of gout and its standard therapy. 2. Highlight febuxostat pivotal trials. 3. Identify febuxostat potential adverse effects and the ramifications in patient's care. 4. Define the place of febuxostat in the treatment of gout.

Update on Drug Shortages webinar Presented by Erin Fox,PharmD, Manager, Drug Information Services University of Utah 6:00 to 7:30 pm 1.5 Contact Hours Registration is open until 3:00 pm on Wednesday, June 6, 2012. Late registrants will only be permitted if time and space is available. All participants attending the webinar on June 6 will receive live CE credit. The recorded webinar is home study credit Refund requests must be made prior to June 6. All requests must be in writing by ma...

Objectives 1. Review major categories of respiratory medications, summarizing mechanisms of action and clinically significant adverse effects. 2. Delineate select toxicities associated within each class of respiratory medication. 3. Highlight select drug interactions associated with each class of respiratory medications. 4. Recognize trends of abuse and related adverse effects for certain respiratory medications, such as dextromethorphan and clenbuterol. 5. Review the pot...

This course is structured to provide essential education regarding the epidemiology, prevention, diagnosis, and treatment of healthcare-associated infections (HAIs). The course begins with background information on the pathogenesis of bacterial infections, transmission of infection in the healthcare setting, and the development of drug resistance. The primary sources of HAIs related to the environment, patient factors, and iatrogenic factors are also discussed. The core of the course is a comp...

There are a myriad of analgesic products sold over-the-counter in drug stores and supermarkets as nonprescription pain relievers. People experiencing dental pain are likely to self-medicate with these nonprescription pain relievers before seeing the dentist. In order for a drug product to achieve nonprescription status, the U.S. Food and Drug Administration (FDA) requires it to be safe and effective. The nonsteroidal anti-inflammatory drugs (NSAIDs) that were originally approved only as prescr...

Session 1 – Diabetes Update: Evidence Based Approaches to the Management of Type 2 Diabetes Session 2 – Thursday: New Drug Update - Part I Session 3 – Friday: New Drug Update - Part II

Treating chronic pain patients is a complex challenge. In 2011, the Institute of Medicine (IOM) released a comprehensive report assessing the impact of pain in America. The report indicates that for the 116 million Americans living with chronic pain, these challenges include not only uncertain diagnosis and social stigma, but also shortcomings in the availability of effective analgesics. In addition, treatment challenges are often compounded by inadequate knowledge among both clinicians and pa...

1. Differentiate the multiple definitions of polypharmacy in order to be able to recognize it in your patient population. 2. Discuss the current data available in evaluating polypharmacy specifically in older adults with cancer and incorporate the data in your evaluation of older patients. 3. Summarize the agents or drug classes that may be deemed inappropriate in older adults to avoid prescribing medications for older patients that may lead to adverse drug events.

Session 1: Evidence-Based Medication Therapy Management: Optimizing Pharmacotherapy Outcomes for our Patients - Part 1 Session 2: Evidence-based Medication Therapy Management: Optimizing Pharmacotherapy Outcomes for Our Patients - Part 2 Session 3: Identifying and Managing Drug-Drug and Drug-Disease Interactions

Postoperative inflammation can lead to serious adverse outcomes. A thorough understanding of the pathophysiology of inflammation is essential in order to develop effective therapeutic strategies that will prevent the long-term ocular sequelae. Clinicians should be aware of the overall efficacy and safety of available topical anti-inflammatory agents as well as differences in drug potency and drug delivery mechanisms. A panel of expert eye surgeons discusses loteprednol etabonate ointment, a re...

In order to prevent overuse and abuse, clinicians, especially pharmacists, must be diligent about monitoring adverse events and potential misuse in their pain patients. Prescription drug abuse is increasing worldwide and Dr. McPherson provides pharmacists with an excellent review of what tools are available to improve assessment and monitoring of pain and drug-related aberrant behaviors. Treatment success can be improved when pain characteristics are properly assessed, and risk of abuse, misu...

This course will provide participants with an understanding of drug safety at the investigational stage and during the marketing phase. Adverse event identification and reporting requirements will be addressed, as well as FDA, EMEA, Health Canada and ICH roles in the drug safety process. The course will also discuss international law/regulations, ICH guidelines, Pharmacovigilance, definitions and current regulatory issues. Adverse event reporting requirements specific to the US, Canada, Japan...

The drugs methylenedioxymethamphetamine (MDMA), ketamine, flunitrazepam, and gamma-hydroxybutyrate (GHB), collectively known as "club drugs," have become widely used by college students and by a segment of the youth population that attends all-night dance parties known as "raves." This course will provide the most pertinent up-to-date information regarding the demographics and characteristics of club drug users, pharmacokinetics and pharmacodynamics, clinical signs and symptoms, and available ...

Learning Objectives: Upon successful completion of this activity, pharmacists should be able to: 1. Define common statistical terms used in drug therapy outcome studies 2. Convert clinical trial results into understandable language when discussing findings with students and the public 3. Describe strengths and limitations of met-analysis studies 4. Develop strategies to discuss journal articles with students through creative learning experiences

This course provides a thorough understanding of the activities involved during Phase 3 and 4 of drug development. The objective is to provide detailed knowledge of project management practices, and tools that will make the difference between a successful clinical trial and one that does not meet its goals. The course will focus on issues that impact late stage R&D, including product launch and commercialization.

Course Description & Objectives * Describe the approach used for a cost-minimization analysis * List the median cost savings associated with dexmedetomidine * Describe the primary factors associated with the cost savings * Compare benzodiazepine usage with propofol * Assess current usage of dexmedetomidine * Determine if type of ICU dictates drug usage * Describe the frequency of use of acid-suppressive drug therapy in outpatients and inpatients * ...

After completing this program participants will be able to: - Select and utilize tobacco, alcohol, and drug use screening tools - Perform brief interventions for tobacco and substance use problems - Refer patients to the appropriate type of substance abuse treatment center and/or specialist - Follow-up with and reassess patients who receive treatment for substance abuse or tobacco use